title: Isotretinoin-induced agranulocytosis.
abstract: Isotretinoin is used to treat a spectrum of dermatologic conditions. The present article reports the case of a 15-year-old female patient who exhibited agranulocytosis after the initiation of isotretinoin administration. Agranulocytosis is a rare but life-threatening side effect of isotretinoin use, and clinicians must be aware of agranulocytosis.
authors.affiliation: Division of Haematology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
authors.forename: Mehmet Akif
authors.initials: MA
authors.lastname: Ozdemir
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kose
authors.forename: Musa
authors.initials: M
authors.lastname: Karakukcu
authors.forename: Ayten
authors.initials: A
authors.lastname: Ferahbas
authors.forename: Turkan
authors.initials: T
authors.lastname: Patiroglu
authors.forename: Esad
authors.initials: E
authors.lastname: Koklu
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*
chemical_list: D015474:Isotretinoin